Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.5.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenues    
Product $ 13,042 $ 9,939
Product licensing fees and royalties 981 3,056
Service 1,061 859
Total revenues 15,084 13,854
Cost of revenues    
Product 6,993 5,908
Service 881 658
Total cost of revenues 7,874 6,566
Gross profit 7,210 7,288
Operating expenses    
Research and development 1,806 1,533
Selling, general and administrative 15,556 12,414
Total operating expenses 17,362 13,947
Loss from operations (10,152) (6,659)
Interest expense (3) (3)
Interest income 2 1
Gain due to change in fair value of derivative instruments 11 3,164
Impairment loss on long-term investment (See Note 3) 0 (4,650)
Other expense, net (20) (56)
Net loss $ (10,162) $ (8,203)
Net loss per common share: Basic and diluted $ (.62) $ (0.85)
Weighted-average number of common shares used in common per share calculations: basic and diluted 16,444 9,657
Other comprehensive loss    
Net loss $ (10,162) $ (8,203)
Foreign currency translation adjustments (347) (438)
Comprehensive loss $ (10,509) $ (8,641)